Results 1 to 10 of about 14,767 (235)
Michel Billiard,1 Karel Sonka2 1Department of Neurology, Gui de Chauliac Hospital, Montpellier, France; 2Department of Neurology and Center of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital, Prague ...
Karel Sonka
exaly +4 more sources
Clinical considerations for the diagnosis of idiopathic hypersomnia
Idiopathic hypersomnia is a sleep disorder of neurologic origin characterized by excessive daytime sleepiness, with sleep inertia, long, unrefreshing naps, and prolonged nighttime sleep being key symptoms in many patients.
Richard Bogan, Isabelle Arnulf
exaly +2 more sources
Characteristics of adults newly diagnosed with idiopathic hypersomnia in the United States
Background: Idiopathic hypersomnia is a debilitating sleep disorder; however, little is known about the clinical presentation of patients receiving this diagnosis.
Ragy Saad +3 more
doaj +2 more sources
The Clinical, Humanistic, and Economic Burden of Idiopathic Hypersomnia in the United States: Analysis of the National Health and Wellness Survey [PDF]
Caroleen Drachenberg,1 M Janelle Cambron-Mellott,2 Lin Yang,2 Bridget L Balkaran,2 Marisa Whalen,3 David T Plante4 1Global Value & HEOR, Jazz Pharmaceuticals, Palo Alto, CA, USA; 2Oracle Life Sciences, Oracle Corporation, Austin, TX, USA; 3US Medical
Drachenberg C +5 more
doaj +2 more sources
Logan Douglas Schneider,1 Joanne Stevens,2 Aatif M Husain,3 Diane Ito,4 Douglas S Fuller,5 Phyllis C Zee,6 Wayne Macfadden2 1Stanford University Sleep Medicine Center, Stanford University School of Medicine, Stanford, CA, USA; 2Global Medical Affairs ...
Schneider LD +6 more
doaj +2 more sources
Ragy Saad,1 Sarah C Markt,1 Prasheel Lillaney,1 Deb A Profant,1 Douglas S Fuller,2 Elizabeth M Poole,1 Trevor Alvord,3 Patricia Prince,3 Shaina Desai,3 Marisa Whalen,2 Weiyi Ni,1 Jed Black1,4 1Jazz Pharmaceuticals, Palo Alto, CA, USA; 2Jazz ...
Saad R +11 more
doaj +2 more sources
Post-COVID central hypersomnia, a treatable trait in long COVID: 4 case reports
IntroductionFatigue is the most commonly reported post-COVID symptom. A minority of patients also report excessive daytime sleepiness, which could be a target for treatment.MethodsAmong 530 patients with a post-COVID condition, those with excessive ...
Clémence Morelli-Zaher +12 more
doaj +2 more sources
Objective/background: Knowledge of idiopathic hypersomnia symptomatology derives from clinical case series. Web-based registries provide complementary information by allowing larger sample sizes, with greater geographic and social diversity.
Donald Bliwise +2 more
exaly +2 more sources
Differences in the 24-h autonomic nervous activity of outpatients with major depressive disorder with or without hypersomnia: An exploratory observational study [PDF]
Background Hypersomnia, defined as a total sleep time of over 10 h within a 24-h period, is common in patients with major depressive disorder (MDD). The circadian rhythm of patients with hypersomnia and depression is disturbed; however, differences from ...
Etsuko Kita +7 more
doaj +2 more sources
Successful management of trichotillomania in a patient with SSRI-induced hypersomnia: a case report [PDF]
BackgroundTrichotillomania is predominantly managed via serotonergic pharmacotherapy and behavioral interventions. However, options become scarce when patients exhibit extreme intolerance to first-line agents.
Deemah Ateeq Alateeq
doaj +2 more sources

